Induction of lymphocyte cytotoxicity by modification of the effector or target cells with periodate or with neuraminidase and galactose oxidase
- PMID: 163281
Induction of lymphocyte cytotoxicity by modification of the effector or target cells with periodate or with neuraminidase and galactose oxidase
Abstract
Treatment of mouse spleen cells with periodate (NaIO4) or with neuraminidase and galactose oxidase (NAGO) induces blastogenesis and renders the cells cytotoxic to mastocytoma (P815) target cells. Treatment of target cells (P815 cells and turkey erythrocytes) with NaIO4 or with NAGO renders them susceptible to cytolysis by untreated mouse spleen cells. The cytotoxicity induced by NaIO4 is reduced upon reacting the NaIO4-treated, effector or target cells with borohydride or hydroxylamine. Thus the formation of free surface aldehydes on either the effector or target cell induced a cytotoxic effect. It is postulated that cross-linkage via a Schiff base between effector and target cell initiates the cytotoxic effect. Cytotoxicity induced by NaIO4 or NAGO is immunologically nonspecific and is independent of major antigenic differences between effector and target cells. Phagocytic cells are not involved in NaIO4-or NAGO-induced cytotoxicity toward P815 target cells.
Similar articles
-
Studies on the induction and expression of T cell-mediated immunity. XIV. Antigen-nonspecific oxidation-dependent cellular cytotoxicity (ODCC) mediated by sodium periodate oxidation of cytotoxic T lymphocytes.J Immunol. 1983 Sep;131(3):1426-32. J Immunol. 1983. PMID: 6193189
-
Induction of lymphocyte transformation by sequential treatment with neuraminidase and galactose oxidase.Proc Natl Acad Sci U S A. 1973 Jun;70(6):1824-7. doi: 10.1073/pnas.70.6.1824. Proc Natl Acad Sci U S A. 1973. PMID: 4352656 Free PMC article.
-
Increased binding and killing of neuraminidase-galactose oxidase-treated tumor cells by normal macrophages.J Immunol. 1977 Jul;119(1):167-72. J Immunol. 1977. PMID: 194981
-
Studies on the synthetic capacity and antigenic expression of glutaraldehyde-fixed target cells.J Immunol. 1975 Mar;114(3):1126-31. J Immunol. 1975. PMID: 122990
-
Oxidation-induced lymphocyte transformation.Cell. 1976 Jan;7(1):13-20. doi: 10.1016/0092-8674(76)90250-6. Cell. 1976. PMID: 181137 Review. No abstract available.
Cited by
-
Enhancing CAR T function with the engineered secretion of C. perfringens neuraminidase.Mol Ther. 2022 Mar 2;30(3):1201-1214. doi: 10.1016/j.ymthe.2021.11.014. Epub 2021 Nov 20. Mol Ther. 2022. PMID: 34813961 Free PMC article.
-
In vitro proliferation of macrophage depleted human peripheral blood lymphocytes.Clin Exp Immunol. 1979 Dec;38(3):531-8. Clin Exp Immunol. 1979. PMID: 535185 Free PMC article.
-
Neuraminidase and tumor immunotherapy.Klin Wochenschr. 1977 Mar 1;55(5):199-214. doi: 10.1007/BF01487712. Klin Wochenschr. 1977. PMID: 846180
-
T lymphocyte-mediated cytolysis. III. Delineation of mechanisms whereby mitogenic and non-mitogenic lectins mediate lymphocyte-target interaction.Immunology. 1983 Aug;49(4):585-92. Immunology. 1983. PMID: 6603417 Free PMC article.
-
Protein Immobilization on Bacterial Cellulose for Biomedical Application.Polymers (Basel). 2024 Aug 30;16(17):2468. doi: 10.3390/polym16172468. Polymers (Basel). 2024. PMID: 39274101 Free PMC article. Review.